Oxidative stress in heart failure: What are we missing?

American Journal of the Medical Sciences

Volumn 342, Issue 2, 2011, Pages 120-124

  Sawyer, Douglas B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alpha tocopherol; Antioxidant enzymes; itric oxide synthase; Myocardial remodeling; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CALCIUM ION; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE REDUCTASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE SYNTHASE; OXYGEN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SELENIUM; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE; XANTHINE OXIDASE INHIBITOR;

ANTIOXIDANT ACTIVITY; CONFERENCE PAPER; CYTOTOXICITY; HEART FAILURE; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; SELENIUM DEFICIENCY;

EID: 79961021871     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3182249fcd     Document Type: Conference Paper

References (81)

1. Sam F, Kerstetter DL, Pimental D, et al. Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J Card Fail 2005;11:473-80.
2. Tsutsui H, Ide T, Kinugawa S. Mitochondrial oxidative stress, DNA damage, and heart failure. Antioxid Redox Signal 2006;8:1737-44. (Pubitemid 44726346)
3. McMurray J, McLay J, Chopra M, et al. Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease. 1990;65:1261-2.
4. Campolo J, Caruso R, De Maria R, et al. Aminothiol redox alterations in patients with chronic heart failure of ischaemic or nonischaemic origin. J Cardiovasc Med (Hagerstown) 2007;8:1024-8. (Pubitemid 351339560)
5. Tang WH, Brennan ML, Philip K, et al. Plasma myeloperoxidase levels in patients with chronic heart failure. Am J Cardiol 2006;98: 796-9. (Pubitemid 44301017)
6. Watanabe E, Matsuda N, Shiga T, et al. Significance of 8-hydroxy-2′-deoxyguanosine levels in patients with idiopathic dilated cardiomyopathy. J Card Fail 2006;12:527-32. (Pubitemid 44307707)
7. Canton M, Menazza S, Sheeran FL, et al. Oxidation of myofibrillar proteins in human heart failure. J Am Coll Cardiol 2011;57:300-9.
8. Assem M, Teyssier JR, Benderitter M, et al. Pattern of superoxide dismutase enzymatic activity and RNA changes in rat heart ventricles after myocardial infarction. Am J Pathol 1997;151:549-55. (Pubitemid 27330074)
9. Carlsson LM, Jonsson J, Edlund T, et al. Mice lacking extracellular superoxide dismutase are more sensitive to hypoxia. Proc Natl Acad Sci USA 1995;92:6264-8.
10. Li Y, Huang T-T, Carlson EJ, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995;11:376-81.
11. Martini G, Ursini MV. A new lease of life for an old enzyme. 1996;18:631-7.
12. Clark JE, Foresti R, Green CJ, et al. Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem J 2000;348 (Pt 3):615-9. (Pubitemid 30410252)
13. Levy AP, Asleh R, Blum S, et al. Haptoglobin: basic and clinical aspects. Antioxid Redox Signal 2010;12:293-304.
14. Rotruck JT, Pope AL, Ganther HE, et al. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973;179:588-90.
15. Wu J, Xu GL. Plasma selenium content, platelet glutathione peroxidase and superoxide dismutase activity of residents in Kashin-Beck disease affected area in China. J Trace Elem Electrolytes Health Dis 1987;1:39-43.
16. de Lorgeril M, Salen P, Accominotti M, et al. Dietary and blood antioxidants in patients with chronic heart failure. Insights into the potential importance of selenium in heart failure. Eur J Heart Fail 2001;3:661-9. (Pubitemid 33121342)
17. Sato M, Sasaki M, Hojo H. Antioxidative roles of metallothionein and manganese superoxide dismutase induced by tumor necrosis factoralpha and interleukin-6. Arch Biochem Biophys 1995;316:738-44.
18. Samuel SM, Thirunavukkarasu M, Penumathsa SV, et al. Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats. Circulation 2010;121:1244-55.
19. Nimata M, Kishimoto C, Shioji K, et al. Upregulation of redoxregulating protein, thioredoxin, in endomyocardial biopsy samples of patients with myocarditis and cardiomyopathies. Mol Cell Biochem 2003;248:193-6. (Pubitemid 36833659)
20. Jekell A, Hossain A, Alehagen U, et al. Elevated circulating levels of thioredoxin and stress in chronic heart failure. Eur J Heart Fail 2004; 6:883-90. (Pubitemid 39536304)
21. Mallat Z, Philip I, Lebret M, et al. Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 1998;97:1536-9. (Pubitemid 28186180)
22. Kono Y, Nakamura K, Kimura H, et al. Elevated levels of oxidative DNA damage in serum and myocardium of patients with heart failure. Circ J 2006;70:1001-5. (Pubitemid 44161736)
23. Siwik DA, Tzortzis JD, Pimental DR, et al. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res 1999;85: 147-53. (Pubitemid 29343313)
24. Kwon SH, Pimentel DR, Remondino A, et al. H(2)O(2) regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. J Mol Cell Cardiol 2003;35:615-21. (Pubitemid 36677445)
25. Siwik DA, Pagano PJ, Colucci WS. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 2001;280:C53-60.
26. Pimentel DR, Amin JK, Xiao L, et al. Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res 2001;89:453-60. (Pubitemid 34132662)
27. Arstall MA, Sawyer DB, Fukazawa R, et al. Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation [see comments]. Circ Res 1999;85:829-40. (Pubitemid 29504158)
28. Amin JK, Pimentel DR, Chang DF, et al. Superoxide anion mediates norepinephrine-induced hypertrophy, but not contractility, in adult rat ventricular myocytes. Circulation 1998;suppl I:1-422.
29. Communal C, Singh K, Pimentel DR, et al. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation 1998;98:1329-34. (Pubitemid 28443398)
30. Nakamura K, Fushimi K, Kouchi H, et al. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 1998;98: 794-9. (Pubitemid 28391845)
31. Xiao L, Pimentel DR, Wang J, et al. Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. Am J Physiol Cell Physiol 2002;282:C926-34. (Pubitemid 34663155)
32. Cheng TH, Shih NL, Chen SY, et al. Reactive oxygen species modulate endothelin-I-induced c-fos gene expression in cardiomyocytes. Cardiovasc Res 1999;41:654-62. (Pubitemid 29130629)
33. Sugden PH, Clerk A. "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res 1998;83:345-52. (Pubitemid 28389964)
34. Arai M, Alpert NR, MacLennan DH, et al. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 1993;72:463-9. (Pubitemid 23024533)
35. Goldhaber JI, Qayyum MS. Oxygen free radicals and excitationcontraction coupling. Antioxid Redox Signal 2000;2:55-64. (Pubitemid 30202454)
36. 2+exchange in the infarcted heart. Implications for excitation-contraction coupling. Circ Res 1997;81:1083-93. (Pubitemid 27514959)
37. Campbell DL, Stamler JS, Strauss HC. Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol 1996;108: 277-93. (Pubitemid 26332539)
38. Xu L, Eu JP, Meissner G, et al. Activation of the cardiac calcium release channel (Ryanodine receptor) by poly-S-nitrosylation. Science 1998;279:234-7. (Pubitemid 28103882)
39. Borkowski BJ, Cheema Y, Shahbaz AU, et al. Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited [published online ahead of print March 12, 2011]. Eur Heart J. doi: 10.1093/eurheartj/ehr063.
40. Hill MF, Singal PK. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 1996;148:291-300. (Pubitemid 26019664)
41. Dhalla AK, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 1996;28:506-14. (Pubitemid 26274350)
42. Hamblin M, Smith HM, Hill MF. Dietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-prostaglandin F2alpha and oxidized glutathione. J Card Fail 2007;13:884-92. (Pubitemid 350198931)
43. Prasad K, Gupta JB, Kalra J, et al. Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model. J Mol Cell Cardiol 1996;28:375-85. (Pubitemid 26110481)
44. Ghatak A, Brar MJ, Agarwal A, et al. Oxy free radical system in heart failure and therapeutic role of oral vitamin E. Int J Cardiol 1996;57:119-27. (Pubitemid 26423567)
45. Keith ME, Jeejeebhoy KN, Langer A, et al. A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. Am J Clin Nutr 2001;73:219-24. (Pubitemid 32109849)
46. Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005;293:1338-47. (Pubitemid 40381486)
47. Marchioli R, Levantesi G, Macchia A, et al. Vitamin E increases the risk of developing heart failure after myocardial infarction: results from the GISSI-Prevenzione trial. J Cardiovasc Med (Hagerstown) 2006;7: 347-50. (Pubitemid 44145638)
48. Robinson I, de Serna DG, Gutierrez A, et al. Vitamin E in humans: an explanation of clinical trial failure. Endocr Pract 2006;12:576-82. (Pubitemid 46456048)
49. Gutierrez AD, de Serna DG, Robinson I, et al. The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C. Metabolism 2009;58:469-78.
50. Milman U, Blum S, Shapira C, et al. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial. Arterioscler Thromb Vasc Biol 2008;28:341-7. (Pubitemid 351161209)
51. Dhanasekaran A, Kotamraju S, Kalivendi SV, et al. Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis. J Biol Chem 2004;279:37575-87. (Pubitemid 39195471)
52. Ishiyama T, Morita Y, Toyama S, et al. A clinical study of the effect of coenzyme Q on congestive heart failure. Jpn Heart J 1976;17:32-42.
53. Nakamura R, Egashira K, Machida Y, et al. Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: roles of oxidative stress and inflammation. Circulation 2002; 106:362-7. (Pubitemid 34778962)
54. Kinugawa S, Tsutsui H, Hayashidani S, et al. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ Res 2000;87:392-8.
55. Thirunavukkarasu M, Penumathsa SV, Koneru S, et al. Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med 2007;43:720-9. (Pubitemid 47102122)
56. Sakai H, Tsutamoto T, Tsutsui T, et al. Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure. Circ J 2006;70:1006-11. (Pubitemid 44161737)
57. Ekundayo OJ, Dell'Italia LJ, Sanders PW, et al. Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study. Int J Cardiol 2010;142:279-87.
58. Doehner W, Schoene N, Rauchhaus M, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 2002; 105:2619-24. (Pubitemid 34596038)
59. Farquharson CA, Butler R, Hill A, et al. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002;106: 221-6. (Pubitemid 34761303)
60. Cappola TP, Kass DA, Nelson GS, et al. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001;104:2407-11. (Pubitemid 33108372)
61. Cingolani HE, Plastino JA, Escudero EM, et al. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study. J Card Fail 2006;12:491-8. (Pubitemid 44307706)
62. Hare JM, Mangal B, Brown J, et al. Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol 2008;51:2301-9. (Pubitemid 351783365)
63. Griendling KK, Minieri CA, Ollerenshaw JD, et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141-8. (Pubitemid 24176909)
64. Griendling KK, Ushio-Fukai M. Redox control of vascular smooth muscle proliferation. J Lab Clin Med 1998;132:9-15. (Pubitemid 28329605)
65. Murdoch CE, Zhang M, Cave AC, et al. NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc Res 2006;71:208-15.
66. Tsutsui H, Kinugawa S, Matsushima S. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res 2009;81:449-56.
67. Ide T, Tsutsui H, Kinugawa S, et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res 1999;85:357-63. (Pubitemid 29398868)
68. Belge C, Massion PB, Pelat M, et al. Nitric oxide and the heart: update on new paradigms. Ann N Y Acad Sci 2005;1047:173-82. (Pubitemid 41123838)
69. Singh K, Balligand JL, Fischer TA, et al. Regulation of cytokineinducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT1 alpha. J Biol Chem 1996;271:1111-7.
70. Lewis NP, Tsao PS, Rickenbacher PR, et al. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation 1996;93:720-9. (Pubitemid 26052458)
71. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315-424. (Pubitemid 46217686)
72. Ischiropoulos H, Zhu L, Chen J, et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992;298:431-7.
73. 2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. 1998;273:25804-8.
74. Zimmet JM, Hare JM. Nitroso-redox interactions in the cardiovascular system. Circulation 2006;114:1531-44. (Pubitemid 44527009)
75. Pinsky DJ, Cai B, Yang X, et al. The lethal effects of cytokineinduced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta. J Clin Invest 1995;95:677-85.
76. Sam F, Sawyer DB, Xie Z, et al. Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction. Circ Res 2001;89:351-6. (Pubitemid 34132674)
77. Ishiyama S, Hiroe M, Nishikawa T, et al. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation 1997;95:489-96. (Pubitemid 27056218)
78. Mikami S, Kawashima S, Kanazawa K, et al. Low-dose N omeganitro-L- arginine methyl ester treatment improves survival rate and decreases myocardial injury in a murine model of viral myocarditis induced by coxsackievirus B3. Circ Res 1997;81:504-11. (Pubitemid 27432737)
79. Cheng W, Li B, Kajstura J, et al. Stretch-induced programmed myocyte cell death. J Clin Invest 1995;96:2247-59.
80. Mannick JB, Miao XQ, Stamler JS. Nitric oxide inhibits Fas-induced apoptosis. J Biol Chem 1997;272:24125-8. (Pubitemid 27418605)
81. Feng Q, Song W, Lu X, et al. Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation 2002;106:873-9.